Sopic, Miron
Robinson, Emma L.
Emanueli, Costanza
Srivastava, Prashant
Angione, Claudio
Gaetano, Carlo
Condorelli, Gianluigi
Martelli, Fabio
Pedrazzini, Thierry
Devaux, Yvan http://orcid.org/0000-0002-5321-8543
,
Funding for this research was provided by:
Ministry of Education, Science and Technological Development, Republic of Serbia (Grant Agreement with University of Belgrade-Faculty of Pharmacy No: 451-03-9/2021-14/200161)
European Union (HORIZON-MSCA-2021-SE-01-01 - MSCA Staff Exchanges 2021 CardioSCOPE 101086397,HORIZON-MSCA-2021-PF- MAACS 101064175)
American Heart Association (Postdoctoral fellowship (#829504))
Colorado Clinical and Translational Sciences Institute (Pilot Grant award (#CO‐J‐22‐)
Alan Turing Institute (Network Development Award grant TNDC2-100022)
Ricerca Corrente - Rete cardiologica IRCCS
Italian Ministry of Health (“Ricerca Corrente”,RF-2019-12368521)
Italian Cardiology Network IRCCS (RCR-2022-23682288)
Telethon Foundation (#4462 GGP19035A)
AFM-Telethon (# 23054)
EU Horizon 2020 (COVIRNA, Grant #101016072, Project COVIRNA (Grant # 101016072))
cardioRNA COST action
Fonds National de la Recherche Luxembourg (grants # C14/BM/8225223, C17/BM/11613033, COVID-19/2020-1/14719577/miRCOVID)
CardioRNA COST action
Ministère de l'Enseignement Supérieur et de la Recherche
Heart Foundation—Daniel Wagner of Luxembourg
Regione Lombardia ("Progetto Immunhub")
Article History
Received: 3 February 2023
Revised: 27 March 2023
Accepted: 10 April 2023
First Online: 4 May 2023
Declarations
:
: Y.D. owns patents related to diagnostic and therapeutic applications of RNAs.